Found: 19
Select item for more details and to access through your institution.
In Vitro Biophysical and Biological Characterization of Lipid Nanoparticles Co-Encapsulating Oncosuppressors miR-199b-5p and miR-204-5p as Potentiators of Target Therapy in Metastatic Melanoma.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 6, p. 1930, doi. 10.3390/ijms21061930
- By:
- Publication type:
- Article
c-Src Recruitment is Involved in c-MET-Mediated Malignant Behaviour of NT2D1 Non-Seminoma Cells.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 2, p. 320, doi. 10.3390/ijms20020320
- By:
- Publication type:
- Article
Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, n. 1, p. N.PAG, doi. 10.1186/s13046-018-0989-7
- By:
- Publication type:
- Article
CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 3, p. 1877, doi. 10.1002/jcp.29121
- By:
- Publication type:
- Article
Cancer Stem Cells and the Slow Cycling Phenotype: How to Cut the Gordian Knot Driving Resistance to Therapy in Melanoma.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3368, doi. 10.3390/cancers12113368
- By:
- Publication type:
- Article
ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma: Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin.
- Published in:
- Cancers, 2019, v. 11, n. 10, p. 1425, doi. 10.3390/cancers11101425
- By:
- Publication type:
- Article
The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.645069
- By:
- Publication type:
- Article
Role of WT1–ZNF224 interaction in the expression of apoptosis-regulating genes.
- Published in:
- Human Molecular Genetics, 2013, v. 22, n. 9, p. 1771, doi. 10.1093/hmg/ddt027
- By:
- Publication type:
- Article
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 3, p. 1, doi. 10.1038/s41419-024-06580-2
- By:
- Publication type:
- Article
Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 11, p. 1, doi. 10.1038/s41419-019-2048-5
- By:
- Publication type:
- Article
ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors.
- Published in:
- Journal of Translational Medicine, 2015, v. 13, p. 1, doi. 10.1186/1479-5876-13-S1-K3
- By:
- Publication type:
- Article
Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-180
- By:
- Publication type:
- Article
Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02878-9
- By:
- Publication type:
- Article
The new world of RNA diagnostics and therapeutics.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02752-8
- By:
- Publication type:
- Article
Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 163, n. 1, p. 47, doi. 10.1007/s11060-023-04287-6
- By:
- Publication type:
- Article
Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma.
- Published in:
- Theranostics, 2022, v. 12, n. 17, p. 7420, doi. 10.7150/thno.77761
- By:
- Publication type:
- Article
microRNA-378a-5p iS a novel positive regulator of melanoma progression.
- Published in:
- Oncogenesis, 2020, v. 9, n. 2, p. 1, doi. 10.1038/s41389-020-0203-6
- By:
- Publication type:
- Article
Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas: effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization.
- Published in:
- Cell Communication & Signaling, 2020, v. 18, n. 1, p. 1, doi. 10.1186/s12964-020-00633-7
- By:
- Publication type:
- Article